Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026)
Cytosorbents' (CTSO) quarterly Current Deferred Revenue came in at $34000.0 in Q1 2026, down 93.77% YoY from $546028.0 in Q1 2025, and down 81.32% on a QoQ basis from $182000.0 in Q4 2025.
Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 9 years of Current Deferred Revenue data on file, last reported at $34000.0 in Q1 2026.
- Quarterly Current Deferred Revenue fell 93.77% year-over-year to $34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34000.0 (down 93.77% YoY) and the FY2025 annual result came in at $182000.0, down 69.46% from the prior year.
- Current Deferred Revenue fell to $34000.0 in Q1 2026, from $182000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.5 million in Q4 2022 to a low of $34000.0 in Q1 2026.
- A 5-year average of $627452.6 and a median of $474514.0 in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue fell 8.96% — and 2026, when it tumbled 93.77%.
- Tracing CTSO's Current Deferred Revenue over 5 years: stood at $1.5 million in 2022, then dropped by 8.96% to $1.4 million in 2023, then slumped by 56.84% to $596000.0 in 2024, then plunged by 69.46% to $182000.0 in 2025, then tumbled by 81.32% to $34000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $34000.0 (Q1 2026), $182000.0 (Q4 2025), and $403000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 361,000.00 |
| Mar 31, 2025 | 546,028.00 |
| Dec 31, 2024 | 596,000.00 |
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Dec 31, 2020 | 728,351.00 |
| Dec 31, 2014 | 833.00 |
| Sep 30, 2014 | 3,333.00 |
| Jun 30, 2014 | 5,833.00 |
| Mar 31, 2014 | 117,364.00 |
| Dec 31, 2013 | 272,359.00 |
| Sep 30, 2013 | 435,686.00 |